Trials / Unknown
UnknownNCT05463445
Multicenter Observational Study of PSC and IgG4-SC in China
Multicenter Study of Clinical Characteristics and Management of Primary Sclerosing Cholangitis and IgG4-related Sclerosing Cholangitis in China.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aimed to collect demographic features and clinical outcomes in patients diagnosed with PSC and IgG4-SC by utilizing participants database from multiple medical centers across Mainland China. Cross-sectional studies will focus on characterizing clinical presentations and validating diagnostic and prognostic models on Chinese PSC and IgG4-SC patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Only observation | No intervention is needed. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2022-12-31
- Completion
- 2023-07-31
- First posted
- 2022-07-19
- Last updated
- 2022-07-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05463445. Inclusion in this directory is not an endorsement.